ask="34.47"
ask_size="100"
average_daily_volume="62537"
bid="N/A"
bid_size="N/A"
book_value="0.53"
change="-0.16"
change_from_200_day_moving_average="-1.13"
change_from_50_day_moving_average="-0.30"
change_from_52_week_high="-3.88"
change_From_52_week_low="0.24"
change_in_percent="-5.82%"
close="2.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.64"
ebitda="-16.57M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.56"
ex_dividend_date="N/A"
float_shares="5308000"
high="2.78"
high_52_weeks="6.47"
last_trade_date="3/16/2017"
last_trade_price="2.59"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.35"
low_52_weeks="2.35"
market_capitalization="16.31M"
moving_average_200_day="3.72"
moving_average_50_day="2.89"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="2.75"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-30.43%"
percent_change_from_50_day_moving_average="-10.46%"
percent_change_from_52_week_high="-60.00%"
percent_change_from_52_week_low="+10.21%"
previous_close="2.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.19"
price_per_sales="116.94"
revenue="148054.00"
shares_outstanding="6296000"
short_ratio="2.70"
stock_exchange="NCM"
symbol="MBVX"
volume="123099"
weeks_range_52="2.35 - 6.47"
